文献速递头颈外科

口咽癌患者骨髓与肿瘤18F-FDG摄取在PET/CT上的预后价值及炎症与FDG摄取之间的相互作用

Prognostic value of bone marrow and tumor 18F-FDG uptake on PET/CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake.
PubMed 文献 · Head Neck · 2024-03-05

这项观察性研究纳入91例接受根治性治疗的口咽鳞状细胞癌患者,治疗前行FDG-PET/CT并检测血液炎症标志物,中位随访40个月。单因素分析显示骨髓SUVmean及多项肿瘤代谢参数与无复发生发存期相关,校正年龄、性别和分期后仅骨髓SUVmean仍与RFS显著相关。研究提示多个FDG-PET/CT参数可能具有预后价值,且全身炎症可能与骨髓代谢活性相关。

要点

  • 治疗前骨髓SUVmean是唯一经多因素校正后仍与口咽癌无复发生存期独立相关的PET参数。
  • 肿瘤SUVmax、总SUVmean、总SUVmax、总MTV和总TLG在单因素分析中与无复发生存期显著相关。
  • FDG-PET参数与血清炎症标志物之间存在多项相关性,提示全身炎症与骨髓代谢活性可能相关。

核心结论

  • 多个FDG-PET/CT参数可能对口咽鳞状细胞癌的治疗结局具有预后价值,但骨髓SUVmean是研究队列中唯一显示无复发生存期预后价值的独立PET参数。
  • 研究结果可能提示全身炎症与骨髓代谢活性之间存在关联。

研究设计与样本

  • 这是一项观察性研究,纳入91例接受治疗前FDG-PET/CT的口咽鳞状细胞癌患者,治疗以治愈为目的,中位随访40个月。
  • 治疗前采集血样,分析白细胞、红细胞、血小板计数、血红蛋白和C反应蛋白水平;在33例患者亚组中用邻位延伸分析(Olink Proteomics)检测血清免疫蛋白表达。
  • PET参数包括评估骨髓FDG摄取的SUVmeanBM,以及评估原发口咽肿瘤和总肿瘤负荷的SUVmean、SUVmax、总病灶糖酵解(TLG)和代谢肿瘤体积(MTV)。

主要发现

  • 单因素分析显示SUVmeanBM和肿瘤特异性参数(SUVmaxtumor、SUVmeantotal、SUVmaxtotal、MTVtotal、TLGtotal)与无复发生存期(RFS)显著相关。
  • 校正年龄、性别和分期后,仅SUVmeanBM仍与RFS显著相关。
  • Spearman相关分析发现PET参数与炎症标志物之间存在多项相关性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To examine the prognostic value of F-18 fluorodeoxyglucose (FDG) uptake in the bone marrow (BM) for disease recurrence and survival in patients with oropharyngeal squamous cell carcinoma (OP-SCC). The secondary aims were to evaluate the prognostic value of PET/CT parameters for the primary oropharyngeal tumor and total tumor burden, and to assess the correlation between FDG uptake variables and serum inflammatory markers. METHODS: This was an observational study of 91 patients with OP-SCC who underwent pretreatment FDG-PET/CT. The patients' blood samples were collected before treatment, and treatment was administered with the intention to cure. The median follow-up time was 40 months. The PET parameters measured were SUVmeanBM for the assessment of BM FDG uptake, SUVmean, SUVmax, total lesion glycolysis (TLG), and metabolic tumor volume (MTV) for the evaluation of primary oropharyngeal tumor and total tumor burden. Blood samples were analyzed to determine each patient's white cell, red cell, and platelet cell counts, hemoglobin, and C-reactive protein level. In a subgroup of 33 patients, blood serum was analyzed to evaluate the expression of serum immune proteins using a proximity extension assay (Olink Proteomics). RESULTS: The univariate analysis revealed that SUVmeanBM and tumor-specific parameters (SUVmaxtumor, SUVmeantotal, SUVmaxtotal, MTVtotal, TLGtotal) were significantly associated with recurrence-free survival (RFS). After adjusting for age, sex, and stage only SUVmeanBM remained significantly associated with RFS. Spearman's correlation identified several correlations between PET parameters and inflammatory markers. CONCLUSIONS: Our results show that several FDG-PET/CT parameters may have a prognostic value of treatment outcome in patients with OP-SCC. However, SUVmeanBM was the only independent PET parameter that showed a prognostic value for RFS in the study cohort. Moreover, the study findings might suggest an association between systemic inflammation and the metabolic activity in the BM.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Christou CN, Sandström K, Regula N, et al. Prognostic value of bone marrow and tumor 18F-FDG uptake on PET/CT in patients with oropharyngeal cancer and the interplay between inflammation and FDG uptake. Head Neck. 2024. PMID: 38441400. doi:10.1002/hed.27711

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。